NEW YORK (GenomeWeb) – German molecular diagnostics firm Epigenomics today reported that its first quarter revenues decreased 20 percent year over year on lower R&D revenues offset by increases in product and license revenues.

The firm reported revenues of €295,000 ($330,273) versus revenues of €367,000 for the first quarter of 2015. The company said that its product revenues increased 10 percent to €186,000 from €169,000 in the prior-year period. Licensing income more than doubled to €103,000 from €41,000 while R&D income plummeted to €6,000 from €157,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.